First human test of new drug begins
NCT ID NCT05724797
Summary
This was the first study to test a new drug called NRS 033 in people. The main goal was to check its safety and see how the body absorbs and processes it. The study involved 24 healthy adults who received a single dose and were closely monitored for side effects. This early research helps decide if the drug is safe enough for future testing in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Frontage Clinical Research Center
Secaucus, New Jersey, 07094, United States
Conditions
Explore the condition pages connected to this study.